Photo by Chokniti Khongchum on Pexels

Science

I'm experienced with covering oncology research, scientific breakthroughs, patient stories, and cancer care. Seeking opportunities to cover a range of topics, including the climate crisis, biomedical research, psychological sciences, regenerative systems, and environmental justice.

Photo by Alex wolf mx on Pexels

Diversifying Data and Addressing Disparities for Older Hispanic and Latino Patients

From language barriers to a lack of insurance, limited health care access, and financial hardships, older Hispanic and Latino patients face an onslaught of obstacles when it comes to navigating cancer care. Without diverse, insightful, nuanced health care data about Hispanic and Latino patients, particularly in older adults, providing better resources and improved outcomes becomes even more difficult. This is exactly the problem that Fernando Diaz, MD, hopes to address.
Photo by Edward Jenner on Pexels

Impact Stories: Empowering Innovation and Delivering Meaningful Results in Cancer Care

To accelerate scientific breakthroughs, enhance health equity, and improve patient outcomes for all, Conquer Cancer supports some of the most promising oncology research and programs around the world. This includes supporting efforts that advance not only research, but also continuing education for oncology providers and promotion of the highest-quality, equitable patient care.
Photo by Matthias Zomer on Pexels

Leveraging Surgery to Mitigate Lymphedema and Improve Pain Management for Patients

For patients with breast cancer, the effects of lymphedema can have a profound impact on quality of life. While sufficient research exists on the localized inflammation caused by lymphedema, few studies have explored how this condition affects the body as a whole. Even fewer—if any—have looked at how lymphedema-correcting surgeries could help. It’s a problem that Dionisia Quiroga, DO, PhD, hopes to solve.
Photo by Pixabay on Pexels

Personalizing Treatments for Patients With Metastatic Uterine Leiomyosarcoma

Accounting for less than 1% of cancer diagnoses each year and between 10% to 20% of sarcomas overall, leiomyosarcomas are both aggressive and highly recurrent—with patients facing a 50% rate of recurrence and, for metastatic disease, an average survival of just 12 to 18 months. While this aggressive tumor can occur in anyone, it’s most likely to affect the uterus, making it most common among women and people with female reproductive organs.
Photo by Catalina Carvajal Herrera on Pexels

Colombian Researcher Leverages Immunity to Help Treat Patients With HPV and Lung Cancer

In Colombia, lung cancer is among the most frequent types of cancer and is the second leading cause of cancer-related death in patients with male sex characteristics. Here, patients often present with additional diseases that are linked to lung cancer diagnoses, including human papillomavirus (HPV). Despite the harmful effects and negative reputation of HPV, the infection could help doctors more effectively guide the course of care for patients with certain types of lung cancers.
Photo by Singkham on Pexels

Conquer Cancer Grant Recipients Bring Research IDEAs to LIFe

An eager group of oncologists from around the world enters the ASCO Annual Meeting for the first time. The oncologists—recipients of the International Development and Education Award (IDEA) from ASCO and Conquer Cancer, the ASCO Foundation—belong to this global community of the brightest minds in cancer research. Each of them shares a vision to advance research and care for patients in their home country.
Load More